179 related articles for article (PubMed ID: 29434151)
1. Primary Central Nervous System Post-transplant Lymphoproliferative Disorder Diagnosed by Peripheral Facial Nerve Palsy.
Imafuku A; Tanaka K; Marui Y; Ubara Y; Takaichi K; Tomikawa S; Ota Y; Fujii T; Ishii Y
Intern Med; 2018 Jul; 57(13):1899-1903. PubMed ID: 29434151
[TBL] [Abstract][Full Text] [Related]
2. Reduction of immunosuppression combined with whole-brain radiotherapy and concurrent systemic rituximab is an effective yet toxic treatment of primary central nervous system post-transplant lymphoproliferative disorder (pCNS-PTLD): 14 cases from the prospective German PTLD registry.
Zimmermann H; Nitsche M; Pott C; Reinke P; Babel N; Hermann RM; Hauser IA; Hahn D; Ritgen M; Pietschmann C; Klapper W; Anagnostopoulos I; Trappe RU;
Ann Hematol; 2021 Aug; 100(8):2043-2050. PubMed ID: 33973053
[TBL] [Abstract][Full Text] [Related]
3. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
Wasson S; Zafar MN; Best J; Reddy HK
J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222
[TBL] [Abstract][Full Text] [Related]
4. EBV-positive post-transplant lymphoproliferative disorder presenting as primary diffuse large B-cell lymphoma of the central nervous system.
Xu H; Rewerska J; Aardsma N; Slavin K; Valyi-Nagy T; Ni H
Folia Neuropathol; 2017; 55(3):221-226. PubMed ID: 28984115
[TBL] [Abstract][Full Text] [Related]
5. A case series of primary central nervous system posttransplantation lymphoproliferative disorder: imaging and clinical characteristics.
Lake W; Chang JE; Kennedy T; Morgan A; Salamat S; Başkaya MK
Neurosurgery; 2013 Jun; 72(6):960-70; discussion 970. PubMed ID: 23685504
[TBL] [Abstract][Full Text] [Related]
6. [Primary central nervous system post-transplant lymphoproliferative disorders].
Honda M; Koga M; Kanda T
Brain Nerve; 2014 Aug; 66(8):947-54. PubMed ID: 25082316
[TBL] [Abstract][Full Text] [Related]
7. Primary CNS lymphoproliferative disease, mycophenolate and calcineurin inhibitor usage.
Crane GM; Powell H; Kostadinov R; Rocafort PT; Rifkin DE; Burger PC; Ambinder RF; Swinnen LJ; Borowitz MJ; Duffield AS
Oncotarget; 2015 Oct; 6(32):33849-66. PubMed ID: 26460822
[TBL] [Abstract][Full Text] [Related]
8. Primary Central Nervous System Post-transplant Lymphoproliferative Disorder Misdiagnosed as Glioblastoma: A Case Report.
Tanaka H; Matsuda R; Nakamura M; Nakagawa I; Nakase H
Anticancer Res; 2022 Aug; 42(8):3975-3979. PubMed ID: 35896237
[TBL] [Abstract][Full Text] [Related]
9. [Subacute cognitive impairment and urinary retention due to primary central nervous system post-transplant lymphoproliferative disorder: a case report].
Yokoyama N; Kanbayashi T; Kobayashi S; Ishida T; Sonoo M
Rinsho Shinkeigaku; 2021 Nov; 61(11):750-755. PubMed ID: 34657922
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of kidney retransplantation in recipients with prior post-transplant lymphoproliferative disorder.
Rouphael B; Lankireddy S; Lazaryan A; Kukla A; Ibrahim HN; Matas AJ; Issa N
Clin Transplant; 2016 Jan; 30(1):60-5. PubMed ID: 26497471
[TBL] [Abstract][Full Text] [Related]
11. [Remission induced by dose-reduction of immunosuppressants alone in a patient with post-transplant lymphoproliferative disorder of central nervous system origin].
Minauchi K; Koizumi K; Kondo M; Takigami M; Harada H; Fujita H; Mukai M
Rinsho Ketsueki; 2011 May; 52(5):272-7. PubMed ID: 21646772
[TBL] [Abstract][Full Text] [Related]
12. Thirteen-And-A-Half Syndrome.
Allbon DS; La Hood B
J Neuroophthalmol; 2016 Jun; 36(2):191-2. PubMed ID: 26928599
[TBL] [Abstract][Full Text] [Related]
13. Primary central nervous system posttransplantation lymphoproliferative disorder after heart and lung transplantation.
Gifford G; Fay K; Jabbour A; Ma DD
Intern Med J; 2015 May; 45(5):583-6. PubMed ID: 25955465
[TBL] [Abstract][Full Text] [Related]
14. Rituximab therapy and reduction of immunosuppression to rescue graft function after renal posttransplantation lymphoproliferative disorder found by macrohematuria in a pancreas and kidney transplant recipient: a case report.
Miyagi S; Sekiguchi S; Kawagishi N; Akamatsu Y; Satoh K; Takeda I; Fukushima D; Kobayashi Y; Tokodai K; Fujimori K; Satomi S
Transplant Proc; 2011 Nov; 43(9):3299-301. PubMed ID: 22099782
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility-weighted imaging and diffusion-weighted imaging findings in central nervous system monomorphic B cell post-transplant lymphoproliferative disorder before and after treatment and comparison with primary B cell central nervous system lymphoma.
Ginat DT; Purakal A; Pytel P
J Neurooncol; 2015 Nov; 125(2):297-305. PubMed ID: 26341369
[TBL] [Abstract][Full Text] [Related]
16. Primary central nervous system post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation: a case report.
Tugend M; Dattero J; Shore T; Korobeynikov V; Sekula RF
Front Oncol; 2024; 14():1284577. PubMed ID: 38313803
[TBL] [Abstract][Full Text] [Related]
17. Low viral load post-transplant lymphoproliferative disease localized within the tongue.
Henry DD; Hunger SP; Braylan RC; Dharnidharka VR
Transpl Infect Dis; 2008 Dec; 10(6):426-30. PubMed ID: 18657087
[TBL] [Abstract][Full Text] [Related]
18. Central nervous system lymphoproliferative disorder in pediatric kidney transplant recipients.
Traum AZ; Rodig NM; Pilichowska ME; Somers MJ
Pediatr Transplant; 2006 Jun; 10(4):505-12. PubMed ID: 16712612
[TBL] [Abstract][Full Text] [Related]
19. Facial nerve neurinoma presenting as middle cranial fossa and cerebellopontine angle mass: a case report.
Devi BI; Panigrahi M; Jaiswal VK; Bhat DI; Das S; Das BS
Neurol India; 2000 Dec; 48(4):385-7. PubMed ID: 11146608
[TBL] [Abstract][Full Text] [Related]
20. Native kidney posttransplant lymphoproliferative disorder in a renal transplant recipient.
Chandra A; Kaul A; Aggarwal V; Srivastava D
Saudi J Kidney Dis Transpl; 2017; 28(4):942-944. PubMed ID: 28748904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
